NEXALIN TECHNOLOGY INC- 27 (NXLIW) Stock News

NASDAQ:NXLIW - Nasdaq - - Currency: USD

0.069 +0.01 (+19.38%)

Technical Analysis

NXLIW Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

2 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

3 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

4 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

4 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

4 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

4 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

5 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

6 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23

6 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23

6 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025

6 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025

7 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

7 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

8 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

8 months ago - By: Nexalin Technology, Inc. - Mentions: NXL

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market